blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0778277

EP0778277 - Substituted heterocyclic derivatives as CRF antagonists [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.04.2004
Database last updated on 26.07.2024
Most recent event   Tooltip30.10.2009Change - representativepublished on 02.12.2009  [2009/49]
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [1997/24]For all designated states
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Inventor(s)01 / Chen, Yuhpyng L.
8 Waterview Drive
Waterford, Connecticut 06385 / US
[1997/24]
Representative(s)Eddowes, Simon, et al
Urquhart-Dykes & Lord LLP
30 Welbeck Street
London W1G 8ER / GB
[N/P]
Former [2009/49]Eddowes, Simon, et al
Urquhart-Dykes & Lord LLP 30 Welbeck Street
London W1G 8ER / GB
Former [2000/48]Eddowes, Simon, et al
Urquhart-Dykes & Lord, 30 Welbeck Street
London, W1G 8ER / GB
Former [1997/24]Ruddock, Keith Stephen, et al
Pfizer Limited, European Patent Department, Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Application number, filing date96308092.407.11.1996
[1997/24]
Priority number, dateUS1995000839608.12.1995         Original published format: US 8396
[1997/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP0778277
Date:11.06.1997
Language:EN
[1997/24]
Type: B1 Patent specification 
No.:EP0778277
Date:25.06.2003
Language:EN
[2003/26]
Search report(s)(Supplementary) European search report - dispatched on:EP11.04.1997
ClassificationIPC:C07D487/04, A61K31/52, C07D471/04, C07D473/34, C07D498/04, // (C07D487/04, 239:00, 209:00)
[1997/24]
CPC:
C07D471/04 (EP); A61P1/00 (EP); A61P1/04 (EP);
A61P11/06 (EP); A61P11/08 (EP); A61P13/00 (EP);
A61P13/02 (EP); A61P15/00 (EP); A61P17/00 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P25/00 (EP);
A61P25/04 (EP); A61P25/08 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/20 (EP); A61P25/22 (EP);
A61P25/24 (EP); A61P25/26 (EP); A61P25/28 (EP);
A61P25/30 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P3/08 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/12 (EP); A61P5/14 (EP); A61P9/00 (EP);
A61P9/04 (EP); A61P9/06 (EP); A61P9/12 (EP);
C07D473/34 (EP); C07D487/04 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1997/24]
TitleGerman:Substitutierte heterozyclische Derivate als CRF Antagonisten[1997/24]
English:Substituted heterocyclic derivatives as CRF antagonists[1997/24]
French:Derivés hétérocycliques substitués comme CRF antagonistes[1997/24]
Examination procedure14.11.1996Examination requested  [1997/24]
22.10.1999Despatch of a communication from the examining division (Time limit: M06)
01.08.2000Reply to a communication from the examining division
14.11.2000Despatch of a communication from the examining division (Time limit: M06)
12.09.2001Reply to a communication from the examining division
14.02.2002Despatch of a communication from the examining division (Time limit: M06)
27.09.2002Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
25.11.2002Reply to a communication from the examining division
17.12.2002Communication of intention to grant the patent
22.04.2003Fee for grant paid
22.04.2003Fee for publishing/printing paid
Opposition(s)26.03.2004No opposition filed within time limit [2004/25]
Request for further processing for:25.11.2002Request for further processing filed
25.11.2002Full payment received (date of receipt of payment)
Request granted
06.12.2002Decision despatched
12.09.2001Request for further processing filed
12.09.2001Full payment received (date of receipt of payment)
Request granted
24.09.2001Decision despatched
01.08.2000Request for further processing filed
01.08.2000Full payment received (date of receipt of payment)
Request granted
17.08.2000Decision despatched
Fees paidRenewal fee
08.10.1998Renewal fee patent year 03
05.10.1999Renewal fee patent year 04
23.11.2000Renewal fee patent year 05
17.09.2001Renewal fee patent year 06
11.10.2002Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0157637  (WELLCOME FOUND [GB]) [X] 1-18 * claim 1 *;
 [X]US4725601  (UEDA IKUO [JP], et al) [X] 1-18 * column 1 *;
 [X]US4904666  (FRIEBE WALTER-GUNAR [DE], et al) [X] 1-18 * claim 1 *;
 [X]US5028605  (SABLAYROLLES CLAIRE [FR], et al) [X] 1-18* claim 1 *;
 [X]WO9413677  (PFIZER [US], et al) [X] 1-18 * page 17; claim 1 *;
 [X]WO9413676  (PFIZER [US], et al) [X] 1-18 * page 15; claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.